Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Astrazeneca Plc (AZN)

GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon 4/13/2026 4:30:46 AM

AstraZeneca: Imfinzi, Imjudo Combo With Lenvatinib And TACE Show Positive Phase III Trial Results 4/2/2026 2:46:14 AM

AstraZeneca Announces Positive Results From EMERALD-3 Phase III Trial 4/2/2026 2:03:43 AM

AstraZeneca: Efzimfotase Alfa Shows Positive Results From Phase III Programme 3/31/2026 2:59:03 AM

AstraZeneca Says Efzimfotase Alfa Demonstrated Positive Results From Phase III Trial In Hypophosphatasia 3/31/2026 2:30:33 AM

Biotech Stocks Facing FDA Decision In April 2026 3/30/2026 6:14:27 AM

AstraZeneca Stock Rises 4% Over Positive Data From Tozorakimab Study 3/27/2026 10:22:14 AM

AstraZeneca's Tozorakimab Meets Primary Endpoint In Phase III COPD Trials 3/27/2026 3:29:02 AM

AstraZeneca Says Tozorakimab Meets Primary Endpoint In OBERON And TITANIA Phase III Trials 3/27/2026 3:06:13 AM

AstraZeneca Secures EU Nod For Imfinzi Plus FLOT Chemotherapy In Gastric, GEJ Cancers 3/16/2026 3:29:07 AM

AstraZeneca: EU Approves Imfinzi Plus FLOT Chemo For Patients With Early Gastric And Gastroesophageal Cancers 3/16/2026 3:04:18 AM

Weekly Buzz: BMY Wins FDA Nod; EU Okays JNJ's AKEEGA; IPSEY Withdraws Tazverik, DAWN Acquired 3/13/2026 10:14:13 AM

AstraZeneca Announces Approval Of Koselugo In Canada 3/9/2026 8:41:09 AM

Health Canada Approves Alexion’s Koselugo For Adults With NF1 And Inoperable Plexiform Neurofibromas 3/9/2026 8:07:41 AM

AstraZeneca And Daiichi Sankyo's ENHERTU Granted Priority Review In U.S. For HER2-Positive Breast Cancer 3/9/2026 7:20:51 AM

Daiichi Sankyo: FDA Grants Priority Review For ENHERTU 3/9/2026 3:01:50 AM

Daiichi Sankyo & AstraZeneca’s ENHERTU Gets FDA Priority Review For Residual HER2+ Breast Cancer 3/9/2026 2:34:07 AM

AstraZeneca Prices $2 Bln Three Tranche Bond Offering 2/26/2026 2:56:04 AM

AstraZeneca Prices $2 Bln Bond Offering 2/26/2026 2:40:58 AM

AstraZeneca Non-Executive Director Nazneen Rahman To Retire From The Board 2/24/2026 2:30:44 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap